What will the average number of measles cases be during Trump's term?
Assuming the market's binary question is whether the 4‑year (2025–2028) average annual measles cases will be >= 2,000, I assess an 80% probability that the average will meet or exceed that threshold.
Analysis
**Assumption and framing (required):** The event description supplied is ambiguous about the numeric threshold that defines the Yes/No outcome. Based on the context provided (2025 = 2,289 cases; 2026 already >2,200 as of July and projected to exceed 2025), the most natural and material binary threshold to evaluate is whether the *4‑year average annual measles cases (2025–2028) will be at least 2,000 per year*. I adopt that interpretation for my independent assessment below.
Stage 1 — BLIND ANALYSIS (ignore current market price)
- *Data snapshot and trend:* 2025 recorded 2,289 confirmed cases. As of July 9, 2026 there were 2,231 confirmed cases in 2026 and 4,520 confirmed cases cumulatively from Jan 1, 2025 through July 9, 2026. Annualizing the 18+ month span gives an implied annualized rate near ~2,950 cases/year (4520 cases over ~1.53 years ≈ 2,954/year), which is substantially above 2,000/year.
- *What it would take to drop below the 2,000 threshold:* With 2,289 in 2025 and a projected 2026 ≈ 2,500–2,800, the sum for the first two years of the term is roughly 4,800–5,100. To pull the 4‑year average below 2,000, 2027 and 2028 combined would need to average well under ~1,400 per year (i.e., an improbable ~1,000–1,400 each), implying an extremely fast and sustained reduction (50–60% year‑over‑year declines starting immediately).
- *Mechanisms that make large declines unlikely in the near term:* measles is highly contagious, immunity pockets are geographically clustered, and current policy/social drivers cited in the brief (vaccination restrictions, politicized child‑health policy) suggest continued vulnerability. The weekly average surge (58/week since Jan 2025 vs historical 4/week) points to a structural shift in transmission dynamics rather than a one‑off spike.
- *Independent probability judgment:* Given the current baseline, momentum through mid‑2026, and realistic speed of public‑health recovery (vaccine campaigns, school-entry mandates, etc. take time to raise coverage and close immunity gaps), it is far more likely than not that the 4‑year average will remain >=2,000/year. I put the independent probability at **80%** for Yes under the threshold assumption above.
Stage 2 — MARKET CALIBRATION (examine current market price and explain divergence)
- *Current market:* Yes = 0.28, No = 0.72. The market is signaling that participants believe the 4‑year average will most likely be below the threshold (or participants are pricing large uncertainty or ambiguous question wording).
- *Why the market might be underpricing Yes:* - **Ambiguity discounting:** Traders may be punishing the contract for poor wording/uncertainty about what 'average' means (calendar vs rolling) or what exact numeric threshold applies. When an event is ambiguous markets often converge toward a middle/No bias. - **Overweighting potential mitigation:** Some participants may be over‑confident that aggressive vaccination drives, emergency funding, or policy reversals will rapidly suppress outbreaks beginning in 2027, driving the market toward No. - **Recency and mean‑reversion bias:** Some traders assume outbreaks will revert quickly to low historical levels, underestimating momentum and spatial clustering of susceptibility. - **Information asymmetry / liquidity effects:** The event has sizeable volume but participants may include retail traders reacting emotionally to headlines or hedgers with asymmetric payouts; that can push price away from the objective likelihood.
- *Why the market could be right (partial justification for the 28% Yes):* Rapid, well‑resourced public health responses can sharply blunt transmission. If 2027–2028 see intense vaccination catch‑up campaigns, school mandates reinstated, or if the 2026 figure ends up lower than current trajectories without widespread geographic spread, the multi‑year average could fall below the assumed threshold. Markets may be pricing that possibility and accounting for tail risks I consider unlikely.
- *Final calibration:* I see the market at 28% as *too pessimistic* about sustained high rates. The data through mid‑2026 imply strong inertia; while a downtrend is possible, the pace required to pull a 4‑year average under 2,000/year is rapid and unlikely given current drivers. Hence I retain my independent 80% Yes probability.
(If the market's binary threshold is actually some different number than I assumed, recalibration is required — please confirm the numeric threshold if you need a probability tied to a different cutoff.)
Arguments
For
- Recent confirmed counts are already well above historical levels (2,289 in 2025; 2,231 by July 9, 2026), giving the multi‑year average a high floor.
- Annualized rate from Jan 2025–Jul 2026 (~2,950/year) implies sustained high incidence unless there is a dramatic and rapid reversal.
- Structural drivers (policy environments that reduce vaccination coverage, misinformation, clustering of unvaccinated children) make fast reductions unlikely across all affected geographies.
- Measles' high R0 and geographic pockets of low immunity favor continued outbreaks and recurrent transmission rather than immediate rollback to pre‑2025 baselines.
Against
- Public health can and does respond: targeted vaccination drives, emergency funding, school‑entry enforcement and catch‑up campaigns could substantially reduce transmission over 12–24 months.
- Natural depletion of susceptibles in heavily hit communities could cause case counts to fall in subsequent years, helping push the 4‑year average down.
- Behavioral changes (parents seeking vaccination after local outbreaks) can produce faster-than-expected increases in coverage in key areas.
- Surveillance or reporting changes (case definition tightening, reduced testing) could lower reported counts even if transmission continues at some level.
Key drivers
- Current case momentum and elevated weekly average (58/week since Jan 2025 vs historic 4/week)
- Vaccination coverage changes driven by state policy, school-entry laws, and misinformation dynamics
- Geographic clustering of susceptible populations & importation pressure
- Public health response speed and scale (surge vaccination campaigns, funding, mandates)
Risk factors
- Rapid, large-scale vaccination catch-up campaigns that substantially raise community immunity in 2027–2028
- Policy reversals or new federal/state interventions that mandate or strongly incentivize childhood vaccination
- Natural epidemic burnout / depletion of susceptibles in high‑transmission pockets leading to quick declines
- Data revisions, underreporting/overreporting, or definitional changes in 'confirmed' cases affecting totals
Scenarios
Best case
Sustained high transmission: 2026 ends ~2,700–3,000 cases, 2027–2028 remain elevated (1,800–2,500 each) due to persistent pockets of low immunity and slow policy change. The 4‑year average stays above 2,000 by a comfortable margin (Yes outcome), and measles becomes an ongoing moderate endemic threat for the term.
Most likely
Partial decline but not collapse: 2026 ends as a record year (~2,500–2,800), 2027 shows moderate reduction (~1,200–1,800) as interventions begin to take effect, and 2028 improves further (~800–1,400). The 4‑year average is near the threshold but remains at or slightly above 2,000 — resulting in a Yes outcome under my assumed cutoff.
Worst case
Rapid control: robust nationwide catch‑up vaccination campaigns, reinstated school‑entry checks, and emergency federal action in 2026–2027 sharply reduce incidence to few hundreds per year in 2027–2028. Aggressive mitigation plus natural local exhaustion of outbreaks pulls the 4‑year average below 2,000 (No outcome).
More from this day
- PoliticsKalshi1y
2026: Trump's dream year?
AI72%MKT6%Edge+66Hidden GemGiven that the three policy pillars of the bull case (tax cuts/deregulation, likely Fed rate cuts, and a weakening of regulatory restraints via the Supreme Court) are already in place, the outcome now primarily hinges on the 2026 midterms and a small residual macro/geo risk; I assess a substantially higher chance of the bull case occurring than the market does.
- PoliticsKalshi2y
Which agencies will Trump eliminate?
AI98%MKT36%Edge+62Hidden GemBased on clear executive actions, formal notifications, mass staff removals, and program cancellations in 2025, I assess with very high confidence that USAID was eliminated as an independent agency during Trump's term.
- techPolymarketEnded
Next Claude Opus released by...?
AI41%MKT97%Edge-56HypedThe market is pricing in a near-certain August Opus launch, but Anthropic's public materials still show Opus 4.8 as the current Opus model and there has been no official new Opus announcement in the past week. I think the true probability is much lower than the market's 97.55% implied price.